Royce & Associates’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-44,000
Closed -$770K 1196
2019
Q1
$770K Sell
44,000
-116,000
-73% -$2.12M 0.01% 880
2018
Q4
$2.78M Sell
160,000
-20,000
-11% -$299K 0.03% 633
2018
Q3
$2.55M Hold
180,000
0.02% 782
2018
Q2
$1.75M Buy
+180,000
New +$2.24M 0.01% 857

Other funds holding VCEL

Royce & Associates's VCEL Position: Q2 2019 in Review

Royce & Associates sold out of Vericel Corp (VCEL) in Q2 2019, closing a stake of 44,000 shares — an estimated $770K sold.

Royce & Associates first reported a position in VCEL in Q2 2018 and held it in 4 quarters. The position peaked at $2.78M in Q4 2018. 137 funds tracked by Wall St. Rank hold VCEL as of Q2 2019.

  • Royce & Associates reported no remaining Vericel Corp position as of Q2 2019 after selling out during the quarter.
  • Royce & Associates sold 44,000 Vericel Corp shares in Q2 2019, an estimated $770K.
  • Royce & Associates first reported a position in Vericel Corp in Q2 2018 and held it in 4 quarters.
  • Royce & Associates's Vericel Corp position peaked at $2.78M in Q4 2018.
  • 137 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2019.

Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.